期刊文献+

内脏脂肪素对巨噬细胞MMP-9的作用及其机制探讨 被引量:1

Effects and mechanism of visfatin on MMP-9 in macrophages
下载PDF
导出
摘要 目的研究内脏脂肪素(visfatin)对巨噬细胞基质金属蛋白酶-9(MMP-9)的作用及其机制。方法体外诱导THP-1单核细胞转化为巨噬细胞。为明确visfatin对MMP-9的作用,细胞分为两组:①巨噬细胞+visfatin12h组;②巨噬细胞+visfatin24h组,两组的visfatin的质量浓度均为:0(对照组)、50、100、200、400ng/mL。采用RT-PCR和Westernblotting测定MMP-9基因和蛋白表达,明胶酶谱法检测MMP-9的活性。为明确visfatin对MMP-9的作用机制,细胞分为五组:①巨噬细胞未加刺激组(对照组);②巨噬细胞+MAPKp38、ERK1/2、JNK信号通路抑制剂预处理1h后加visfatin(200ng/mL)24h组;③巨噬细胞+过氧化物酶体增殖剂活化受体(PPARγ)天然及人工配体/RXR配体预处理1h后加visfatin(200ng/mL)24h组;④巨噬细胞+visfatin(200ng/mL)24h组(Vis200组);⑤巨噬细胞+visfatin(200ng/mL)刺激不同时间组(5、10、15、30、60min)。Western blotting检测MMP-9蛋白和PPARγ蛋白表达及visfatin刺激下巨噬细胞p38、ERK1/2、JNKMAPK磷酸化水平。结果Visfatin能促进MMP-9基因及蛋白表达(P<0.05,P<0.01),同时增强了MMP-9的活性(P<0.01)。p38MAPK、ERK1/2MAPK通路抑制剂及RXR配体抑制visfatin对MMP-9表达具有上调作用;visfatin能促进p38MAPK和ERK1/2MAPK的磷酸化,但不影响PPARγ蛋白的表达。结论Visfatin增加了巨噬细胞炎症因子的表达,该作用与p38MAPK和ERK1/2MAPK信号通路有关;RXR可能参与了该过程。 Objective To investigate the effects and mechanism of visfatin on matrix metalloproteinases-9(MMP-9)expression and invasive activity in macrophages.Methods THP-1 monocytes were induced into macrophages.To investigate the effects of visfatin on MMP-9,cells were divided into 2 groups:①macrophages+visfatin 12 h;②macrophages+visfatin 24 h.The concentrations of visfatin in each group were:0(control),50,100,200,400 ng/mL.MMP-9 mRNA and protein expression were analysed by RT-PCR and Western blotting,and MMP-9 invasive activity was assayed by gelatin zymography.To investigate the mechanism of visfatin on MMP-9,cells were divided into 5 groups:①macrophages without stimulation(control);②macrophages pretreated with MAPK p38,ERK1/2,JNK pathway inhibitor for 1 h,then stimulated with visfatin(200 ng/mL)for 24 h;③macrophages pretreated with retinoid X receptors(RXR)nature ligand or peroxisome proliferators-activated receptor γ(PPARγ)natural/synthetic ligand for 1 h,then stimulated with visfatin(200 ng/mL)for 24 h;④macrophages stimulated with visfatin(200 ng/mL)for 24 h;⑤macophages+visfatin(200 ng/mL)for different time(5,10,15,30,60 min).MMP-9 expression,PPARγ expression,and the effect of visfatin on MAPK phosphorylation were analysed by Western blotting.Results Visfatin not only significantly enhanced MMP-9 mRNA and protein expression in macrophages(P〈0.05,P〈0.01),but also up-regulated MMP-9 invasive activity(P〈0.01).p38 MAPK inhibitor,ERK1/2 MAPK inhibitor and RXR ligand significantly blocked visfatin activity.Visfatin activated the phosphorylation of p38 MAPK and ERK1/2 MAPK,while had no effect on expression of PPARγ protein.ConclusionVisfatin enhances inflammatory factors expression and activity in macrophages which is related with ERK1/2 MAPK and p38 MAPK,and RXR may mediate visfatin activity.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第9期1057-1061,1065,共6页 Journal of Shanghai Jiao tong University:Medical Science
关键词 内脏脂肪素 基质金属蛋白酶 丝裂原活化蛋白激酶 视黄醛X受体 动脉粥样硬化 visfatin matrix metalloproteinase mitogen-activated protein kinase retinoid X receptors atherosclerosis
  • 相关文献

参考文献10

  • 1Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [ J]. J Clin Endocrinol Metab, 2006, 91 ( 1 ) : 295 - 299.
  • 2Adya R, Tan BK, Randeva HS, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced anglogenesis[J]. Cardiovasc Res, 2008, 78(2) : 356 -365.
  • 3Lim M, Martinez T, Jablons D, et al. Tumor-derived EMMPRIN (extracellular matrix metalloprotcinasc inducer) stimulates collagenase transcription through MAPK p38 [ J]. FEBS Lett, 1998, 441 (1): 88 -92.
  • 4Abilleira S, Bevan S, Markus HS. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis [J]. JMedGenet, 2006, 43(12): 897 -901.
  • 5Lindsey ML, Escobar GP, Dobrucki LW, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction[ J]. Am J Physiol Heart Circ Physiol, 2006, 290( 1 ): H232 - H239.
  • 6Dahl T, Yndestad A, Michelsen A, Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization [J]. Circulation, 2007, 115(8) : 972 -980.
  • 7Adya R, Tan BK, Chen J, et al. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis [ J ]. Atherosclerosis, 2009, 205(1) : 113 -119.
  • 8Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors [ J ]. Cell, 1995, 83 (6) : 841 - 850.
  • 9Claudel T, Leibowitz MD, Fievet C, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor[J]. Proc Natl Acad Sci U S A, 2001, 98(5): 2610- 2615.
  • 10Staels B. PPAR gamma and atherosclerosis [ J ]. Curr Med Res Opin, 2005, 21 (Suppl 1): S13-S20.

同被引文献9

  • 1中华医学会心血管病学分会.中华心血管病杂志编辑委员会,不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,:35-04,295.
  • 2Ross R, Glomset J, Kariya B, et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro [J] . Proc Natl Acad Sei USA, 1974, 71 (4) : 1207.
  • 3Finn A V, Nakano M, Narula J, et al. Concept of vulnerable/ unstable plaque[J]. Arterioseler Thromb Vasc Biol, 2010, 30 (7): 1282.
  • 4Libby P, RidkerP, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002, 105 (9): 1135.
  • 5Dahl T B, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization[J]. Circulation, 2007, 115: 972.
  • 6Huang D, Ding Y, Luo W M, et al. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo[J]. Cancer Res, 2008, 68 (1): 81.
  • 7无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量:1979
  • 8晋红宾,段雪涛,张炳填,李鑫辉,易亚桥.栝蒌薤白半夏汤对心肌细胞凋亡及P38MAPK表达的影响[J].中国中医急症,2011,20(12):1942-1944. 被引量:8
  • 9朱贤关,李忠东,王建昌,孟如松.银杏叶提取物对活化血小板刺激人冠状动脉内皮细胞产生ROS以及表达LOX-1和磷酸化p38MAPK的影响[J].中国老年学杂志,2012,32(3):546-548. 被引量:8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部